Emerging therapeutic options against filoviruses

St Patrick Reid, A. C. Shurtleff, Sina Bavari

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The highly pathogenic ebolaviruses and marburgviruses remain a significant human health concern since their discovery over 40 years ago. Sporadic outbreaks resulting in high fatality rates and the potential use of these viruses as bioweapons have prompted intense investigations aimed at identifying therapeutic countermeasures. While recent emphasis has been placed on the development of filovirus vaccine candidates, in particular, the use of replicating or non-replicating vaccine platforms, there has been significant progress made towards the discovery and development of small-molecule and nucleic acid-based therapeutics. A number of these advances have resulted from the identification of new viral or host cell targets. These targets are found through continued investigation and elucidation of the mechanisms underlying viral pathogenesis. In this review, we discuss the progress of these novel small-molecule inhibitors, as well as recent advances in gene targeting against filoviruses. In addition, emerging data on cellular defense systems, such as the antioxidant response, will be addressed.

Original languageEnglish (US)
Pages (from-to)343-351
Number of pages9
JournalDrugs of the Future
Volume37
Issue number5
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Marburgvirus
Vaccines
Ebolavirus
Gene Targeting
Nucleic Acids
Disease Outbreaks
Antioxidants
Viruses
Health
Therapeutics

Keywords

  • Antioxidants
  • Ebolavirus
  • Filoviruses
  • Marburgvirus
  • Small-molecule inhibitors

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Emerging therapeutic options against filoviruses. / Reid, St Patrick; Shurtleff, A. C.; Bavari, Sina.

In: Drugs of the Future, Vol. 37, No. 5, 2012, p. 343-351.

Research output: Contribution to journalReview article

Reid, St Patrick ; Shurtleff, A. C. ; Bavari, Sina. / Emerging therapeutic options against filoviruses. In: Drugs of the Future. 2012 ; Vol. 37, No. 5. pp. 343-351.
@article{423ea1eb15124ba59262f012b9ec7dd8,
title = "Emerging therapeutic options against filoviruses",
abstract = "The highly pathogenic ebolaviruses and marburgviruses remain a significant human health concern since their discovery over 40 years ago. Sporadic outbreaks resulting in high fatality rates and the potential use of these viruses as bioweapons have prompted intense investigations aimed at identifying therapeutic countermeasures. While recent emphasis has been placed on the development of filovirus vaccine candidates, in particular, the use of replicating or non-replicating vaccine platforms, there has been significant progress made towards the discovery and development of small-molecule and nucleic acid-based therapeutics. A number of these advances have resulted from the identification of new viral or host cell targets. These targets are found through continued investigation and elucidation of the mechanisms underlying viral pathogenesis. In this review, we discuss the progress of these novel small-molecule inhibitors, as well as recent advances in gene targeting against filoviruses. In addition, emerging data on cellular defense systems, such as the antioxidant response, will be addressed.",
keywords = "Antioxidants, Ebolavirus, Filoviruses, Marburgvirus, Small-molecule inhibitors",
author = "Reid, {St Patrick} and Shurtleff, {A. C.} and Sina Bavari",
year = "2012",
doi = "10.1358/dof.2012.037.05.1784684",
language = "English (US)",
volume = "37",
pages = "343--351",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "5",

}

TY - JOUR

T1 - Emerging therapeutic options against filoviruses

AU - Reid, St Patrick

AU - Shurtleff, A. C.

AU - Bavari, Sina

PY - 2012

Y1 - 2012

N2 - The highly pathogenic ebolaviruses and marburgviruses remain a significant human health concern since their discovery over 40 years ago. Sporadic outbreaks resulting in high fatality rates and the potential use of these viruses as bioweapons have prompted intense investigations aimed at identifying therapeutic countermeasures. While recent emphasis has been placed on the development of filovirus vaccine candidates, in particular, the use of replicating or non-replicating vaccine platforms, there has been significant progress made towards the discovery and development of small-molecule and nucleic acid-based therapeutics. A number of these advances have resulted from the identification of new viral or host cell targets. These targets are found through continued investigation and elucidation of the mechanisms underlying viral pathogenesis. In this review, we discuss the progress of these novel small-molecule inhibitors, as well as recent advances in gene targeting against filoviruses. In addition, emerging data on cellular defense systems, such as the antioxidant response, will be addressed.

AB - The highly pathogenic ebolaviruses and marburgviruses remain a significant human health concern since their discovery over 40 years ago. Sporadic outbreaks resulting in high fatality rates and the potential use of these viruses as bioweapons have prompted intense investigations aimed at identifying therapeutic countermeasures. While recent emphasis has been placed on the development of filovirus vaccine candidates, in particular, the use of replicating or non-replicating vaccine platforms, there has been significant progress made towards the discovery and development of small-molecule and nucleic acid-based therapeutics. A number of these advances have resulted from the identification of new viral or host cell targets. These targets are found through continued investigation and elucidation of the mechanisms underlying viral pathogenesis. In this review, we discuss the progress of these novel small-molecule inhibitors, as well as recent advances in gene targeting against filoviruses. In addition, emerging data on cellular defense systems, such as the antioxidant response, will be addressed.

KW - Antioxidants

KW - Ebolavirus

KW - Filoviruses

KW - Marburgvirus

KW - Small-molecule inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84952986156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952986156&partnerID=8YFLogxK

U2 - 10.1358/dof.2012.037.05.1784684

DO - 10.1358/dof.2012.037.05.1784684

M3 - Review article

VL - 37

SP - 343

EP - 351

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 5

ER -